US Patent 7129264 Biarylmethyl indolines and indoles as antithromboembolic agents

Patent 7129264 was granted and assigned to Bristol-Myers Squibb on October, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7129264

Date of Patent

October 31, 2006

Patent Application Number

10824025

Date Filed

April 14, 2004

Patent Citations Received

‌

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

‌

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

‌

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

The present invention provides compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7129264 Biarylmethyl indolines and indoles as antithromboembolic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API